Schering-Plough Spent $600K Lobbying Gov't In 1Q

WASHINGTON (AP) — Schering-Plough Corp., a major maker of prescription, consumer and animal health products, spent $600,000 in the first quarter to lobby on health care reform, generic biologic drugs and other issues, according to a recent disclosure form.

That amount is 15 percent more than the Kenilworth, N.J.-based company, which is in the process of being acquired by New Jersey neighbor Merck & Co., spent in the year-ago period.

According to a recent disclosure report, Schering-Plough lobbied on health reform issues including access to coverage, price rebates for drugs bought under the Medicaid program and proposals to require research comparing effectiveness of different medical treatments. ...